诺贝尔奖授予免疫检查点——免疫疗法带来的创新癌症治疗。 - Suppr

Suppr

超能文献

Nobel goes to immune checkpoint-Innovative cancer treatment by immunotherapy.

作者信息

Li Jing, Dong Chen

机构信息

Institute for Immunology and School of Medicine, Tsinghua University, Beijing, 100084, China.

Beijing Key Lab for Immunological Research on Chronic Diseases, Beijing, 100084, China.

出版信息

Sci China Life Sci. 2018 Nov;61(11):1445-1450. doi: 10.1007/s11427-018-9409-7. Epub 2018 Oct 29.

DOI:10.1007/s11427-018-9409-7

PMID:30377902

Abstract

摘要

相似文献

Nobel goes to immune checkpoint-Innovative cancer treatment by immunotherapy.

Sci China Life Sci. 2018 Nov;61(11):1445-1450. doi: 10.1007/s11427-018-9409-7. Epub 2018 Oct 29.

New checkpoint inhibitors ride the immunotherapy tsunami.

Nat Rev Drug Discov. 2013 Jul;12(7):489-92. doi: 10.1038/nrd4066.

At the bedside: CTLA-4- and PD-1-blocking antibodies in cancer immunotherapy.

J Leukoc Biol. 2013 Jul;94(1):41-53. doi: 10.1189/jlb.1212631. Epub 2013 May 10.

Editorial: Immune Checkpoint Molecules and Cancer Immunotherapy.

Front Immunol. 2018 Dec 5;9:2878. doi: 10.3389/fimmu.2018.02878. eCollection 2018.

The immune checkpoint inhibitors: where are we now?

Nat Rev Drug Discov. 2014 Dec;13(12):883-4. doi: 10.1038/nrd4476. Epub 2014 Oct 27.

At the bench: preclinical rationale for CTLA-4 and PD-1 blockade as cancer immunotherapy.

J Leukoc Biol. 2013 Jul;94(1):25-39. doi: 10.1189/jlb.1212621. Epub 2013 Apr 26.

Embracing the complexity in cancer therapy.

Lancet Haematol. 2018 Nov;5(11):e493. doi: 10.1016/S2352-3026(18)30179-0.

Immunological and clinical implications of immune checkpoint blockade in human cancer.

Arch Pharm Res. 2019 Jul;42(7):567-581. doi: 10.1007/s12272-019-01140-1. Epub 2019 Mar 6.

Checkpoint blockade for cancer therapy: revitalizing a suppressed immune system.

Trends Mol Med. 2015 Aug;21(8):482-91. doi: 10.1016/j.molmed.2015.05.005. Epub 2015 Jun 16.

Immune Checkpoint Blockade in Breast Cancer Therapy.

Adv Exp Med Biol. 2017;1026:383-402. doi: 10.1007/978-981-10-6020-5_18.

引用本文的文献

Emerging role of metabolic reprogramming in tumor immune evasion and immunotherapy.

Sci China Life Sci. 2021 Apr;64(4):534-547. doi: 10.1007/s11427-019-1735-4. Epub 2020 Aug 17.

Blocking of the PD-1/PD-L1 interaction by a novel cyclic peptide inhibitor for cancer immunotherapy.

Sci China Life Sci. 2021 Apr;64(4):548-562. doi: 10.1007/s11427-020-1740-8. Epub 2020 Jul 28.

NK Cell-Based Immune Checkpoint Inhibition.

Front Immunol. 2020 Feb 13;11:167. doi: 10.3389/fimmu.2020.00167. eCollection 2020.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Nobel goes to immune checkpoint-Innovative cancer treatment by immunotherapy.

Sci China Life Sci. 2018 Nov;61(11):1445-1450. doi: 10.1007/s11427-018-9409-7. Epub 2018 Oct 29.

New checkpoint inhibitors ride the immunotherapy tsunami.

Nat Rev Drug Discov. 2013 Jul;12(7):489-92. doi: 10.1038/nrd4066.

At the bedside: CTLA-4- and PD-1-blocking antibodies in cancer immunotherapy.

J Leukoc Biol. 2013 Jul;94(1):41-53. doi: 10.1189/jlb.1212631. Epub 2013 May 10.

Editorial: Immune Checkpoint Molecules and Cancer Immunotherapy.

Front Immunol. 2018 Dec 5;9:2878. doi: 10.3389/fimmu.2018.02878. eCollection 2018.

The immune checkpoint inhibitors: where are we now?

Nat Rev Drug Discov. 2014 Dec;13(12):883-4. doi: 10.1038/nrd4476. Epub 2014 Oct 27.

At the bench: preclinical rationale for CTLA-4 and PD-1 blockade as cancer immunotherapy.

J Leukoc Biol. 2013 Jul;94(1):25-39. doi: 10.1189/jlb.1212621. Epub 2013 Apr 26.

Embracing the complexity in cancer therapy.

Lancet Haematol. 2018 Nov;5(11):e493. doi: 10.1016/S2352-3026(18)30179-0.

Immunological and clinical implications of immune checkpoint blockade in human cancer.

Arch Pharm Res. 2019 Jul;42(7):567-581. doi: 10.1007/s12272-019-01140-1. Epub 2019 Mar 6.

Checkpoint blockade for cancer therapy: revitalizing a suppressed immune system.

Trends Mol Med. 2015 Aug;21(8):482-91. doi: 10.1016/j.molmed.2015.05.005. Epub 2015 Jun 16.

Immune Checkpoint Blockade in Breast Cancer Therapy.

Adv Exp Med Biol. 2017;1026:383-402. doi: 10.1007/978-981-10-6020-5_18.

引用本文的文献

Emerging role of metabolic reprogramming in tumor immune evasion and immunotherapy.

Sci China Life Sci. 2021 Apr;64(4):534-547. doi: 10.1007/s11427-019-1735-4. Epub 2020 Aug 17.

Blocking of the PD-1/PD-L1 interaction by a novel cyclic peptide inhibitor for cancer immunotherapy.

Sci China Life Sci. 2021 Apr;64(4):548-562. doi: 10.1007/s11427-020-1740-8. Epub 2020 Jul 28.

NK Cell-Based Immune Checkpoint Inhibition.

Front Immunol. 2020 Feb 13;11:167. doi: 10.3389/fimmu.2020.00167. eCollection 2020.